NFE2L2 and hepatocellular carcinoma: Further studies unraveled that STC2, like Nrf2, functions as a dominant tumor-promoter, because STC2-leading increases in clonogenicity of hepatoma cells and malgrowth of relevant xenograft tumors were almost completely abolished in STC2-/- cells 414.